Saravana Kumar Moorthy
Saravana Kumar Moorthy has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Anandaram Sreekanth
Department of Chemistry, National Institute of Technology, Tiruchirappalli, India
2 shared publications Ashok Kumar Saravana Loganthan
Department of Chemistry, GRT Institute of Engineering and Technology, Tiruttani, India
2 shared publicationsAshok Kumar Saravana Loganathan
Department of Chemistry, GRT Institute of Engineering and Technology, Tiruttani Tiruttani, India
1 shared publicationRavichandran S
Department of Chemistry, Saraswathi Narayanan College, Madurai, India
1 shared publicationSanthosh Kumar K
Department of Chemistry, Saraswathi Narayanan College, Madurai, India
1 shared publicationSarathi Natarajan
GRT Institute of Engineering and Technology
1 shared publication
Latest Publications
- 30 October 2026
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 96 (11) , 340
Pharmaceutical Crystalline Complex of Methylparaben with Active Pharmaceutical Ingredient (API): Preparation, Structural Characterization, and Solid-State Properties
In this study, two novel drug–drug (1 : 1) crystalline complexes of methylparaben (MP) with amantadine (AMA) and rotigotine (ROT) were synthesized and systematically investigated. The crystalline complexes were prepared using the slow solvent evaporation technique, using the free-base forms of the APIs prepared from their hydrochloride salts. Formation of the new solid phases was confirmed through comprehensive solid-state characterization using Fourier transform infrared spectroscopy, UV-visible spectroscopy, Differential Scanning Calorimetry, Powder X-ray Diffraction, Single-Crystal X-ray Diffraction, and 1H NMR spectroscopy. Distinct changes in spectral features, diffraction patterns, and thermal behaviour established the successful generation of crystalline complexes different from the parent drug components. The study highlights the effectiveness of drug–drug co-crystallization involving amine-containing CNS drugs as a viable strategy for modulating the solid-state properties of pharmaceutical ingredients.
- 30 October 2026
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 96 (11) , 340
Pharmaceutical Crystalline Complex of Methylparaben with Active Pharmaceutical Ingredient (API): Preparation, Structural Characterization, and Solid-State Properties
In this study, two novel drug–drug (1 : 1) crystalline complexes of methylparaben (MP) with amantadine (AMA) and rotigotine (ROT) were synthesized and systematically investigated. The crystalline complexes were prepared using the slow solvent evaporation technique, using the free-base forms of the APIs prepared from their hydrochloride salts. Formation of the new solid phases was confirmed through comprehensive solid-state characterization using Fourier transform infrared spectroscopy, UV-visible spectroscopy, Differential Scanning Calorimetry, Powder X-ray Diffraction, Single-Crystal X-ray Diffraction, and 1H NMR spectroscopy. Distinct changes in spectral features, diffraction patterns, and thermal behaviour established the successful generation of crystalline complexes different from the parent drug components. The study highlights the effectiveness of drug–drug co-crystallization involving amine-containing CNS drugs as a viable strategy for modulating the solid-state properties of pharmaceutical ingredients.
- Open Access
- 28 April 2025
- Published by Springer Nature in Research Square
Zn(II) Complexes of a Novel Twisted Carbon-Centred Scorpionate Derived from Bis(thiadiazole)alkanes (CH2(S-tdzMe)2): Synthesis, Structural Characterization and Protein Interaction Studies
A series of novel zinc(II) halide complexes with the versatile twisted scorpionate ligand, bis((5-methyl-1,3,4-thiadiazol-2-yl)thio)methane (CH2(S-tdzMe)2) (1), have been synthesized and characterized. The ligand (1) reacts with ZnX2 (X = Br, Cl, I) in a 1:1 molar ratio to afford the complexes [Zn(CH2(S-tdzMe)2)X2] (X = I (2), Br (3), Cl (4)). These complexes, along with the ligand, were characterized by elemental analysis, FT-IR, HRESI-MS, UV-Vis, and multinuclear NMR spectroscopy. Single crystal X-ray diffraction studies of the ligand (1) and complex (4) revealed a tetrahedral geometry around the zinc(II) ion with the ligand coordinating in a κ2N-fashion. Preliminary interaction studies with bovine serum albumin (BSA) using fluorescence spectroscopy suggest potential protein-binding capability.
- 28 April 2025
- Published by Springer Nature in Research Square
Open AccessZn(II) Complexes of a Novel Twisted Carbon-Centred Scorpionate Derived from Bis(thiadiazole)alkanes (CH2(S-tdzMe)2): Synthesis, Structural Characterization and Protein Interaction Studies
A series of novel zinc(II) halide complexes with the versatile twisted scorpionate ligand, bis((5-methyl-1,3,4-thiadiazol-2-yl)thio)methane (CH2(S-tdzMe)2) (1), have been synthesized and characterized. The ligand (1) reacts with ZnX2 (X = Br, Cl, I) in a 1:1 molar ratio to afford the complexes [Zn(CH2(S-tdzMe)2)X2] (X = I (2), Br (3), Cl (4)). These complexes, along with the ligand, were characterized by elemental analysis, FT-IR, HRESI-MS, UV-Vis, and multinuclear NMR spectroscopy. Single crystal X-ray diffraction studies of the ligand (1) and complex (4) revealed a tetrahedral geometry around the zinc(II) ion with the ligand coordinating in a κ2N-fashion. Preliminary interaction studies with bovine serum albumin (BSA) using fluorescence spectroscopy suggest potential protein-binding capability.